Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
Date:3/11/2009

ide of Italy;
  • The European Medicines Agency (EMEA) granted Premacure AB orphan designation for Insmed's IPLEX(TM) for the prevention of retinopathy of prematurity (ROP) in neonates of less than 32 weeks of gestational age. Premacure AB intends to initiate a phase 2 multicenter trial for IPLEX(TM) in the ROP indication during the second quarter of 2009.
  • "The sale of our FOB assets to Merck represents a watershed moment for Insmed," said Dr. Geoffrey Allan, Ph.D., President and CEO Insmed. "This agreement demonstrates Insmed's world-class clinical capabilities, and provides us with a substantial cash infusion that positions us well for future growth. In the short-term, we expect to be cash neutral for the balance of 2009 as we continue moving ahead with our IPLEX(TM) programs for MMD and ALS. In addition, we intend to pursue a comprehensive and thoughtful analysis to determine the most appropriate use of the proceeds we will receive from Merck. Our objective, though, is to utilize this capital to grow our business, and create additional shareholder value, as we have done through the transaction with Merck."

    Financial Results for Fourth Quarter and Full-year 2008

    Revenues for the fourth quarter ended December 31, 2008 were $2.9 million, up from $2.1 for the corresponding period in 2007. The increase was mainly attributable to an $846,000 increase in cost recovery revenue from our EAP to treat patients with ALS in Italy.

    The net loss for the fourth quarter of 2008 was $4.0 million or $0.03 per share, compared with a net loss of $3.3 million or $0.03 per share in the fourth quarter of 2007.

    R&D expenses increased to $5.4 million from $4.6 million, reflecting an increase in clinical trial activity for our FOB and IPLEX(TM) programs. SG&A Expenses increased to $1.3 million from $0.9 million, du
    '/>"/>

    SOURCE Insmed Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
    2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
    3. Insmed to Appeal Delisting Notification From Nasdaq
    4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
    5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
    6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
    7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
    8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
    9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
    10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
    11. Insmed to Present at CBI Follow-On Biologics Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... ... June 29, 2015 , ... ... around 19% during the forecast period (2015 to 2020). The market is mainly ... government and corporate funding for R&D. However, lack of adequate healthcare and research ...
    (Date:6/29/2015)... 29, 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, ... Petit, has been awarded the Lifetime Achievement Award in ... The Entrepreneur Of The Year Program, ...
    (Date:6/29/2015)... ... 2015 , ... The StampedeCon 2015 Big Data Conference will be ... a row, will bring top technology professionals to St. Louis. Top industry speakers will ... and technology. The event is proudly sponsored by DataStax, Cisco, World Wide Technology, Hortonworks, ...
    (Date:6/29/2015)... , June 29, 2015 ... and medical information products and services, today announced the ... According to the 2014 Journal Citation Reports® (JCR) published ... Impact Factors increase from 2013 to 2014, ahead of ... occupied the top rank in 62 subject categories, up ...
    Breaking Biology Technology:Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2StampedeCon Announces 2015 Agenda 2StampedeCon Announces 2015 Agenda 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3
    ... NEW YORK, Aug. 1, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental ... or "AOBO"), a pharmaceutical company dedicated to improving health ... range of prescription and over the counter ("OTC") products, ... 2011 financial results on Tuesday, August 9, 2011, after ...
    ... Researchers have developed a toolkit that enables them to ... Led by Susan Dymecki, a professor of ... serotonin-producing neurons, observing how mice behave in a normal ... While their findings affirm earlier studies, the researchers used ...
    ... When normal proteins form protein clumps in the body, ... "amyloids," are closely associated with Alzheimer,s disease and type ... knew how these proteins form clumps, then they might ... The physicist Adrian Keller and his colleagues at the ...
    Cached Biology Technology:American Oriental Bioengineering to Announce Second Quarter 2011 Financial Results on August 9, 2011 2Researchers target, switch off serotonin-producing neurons in mice 2Researchers target, switch off serotonin-producing neurons in mice 3In the pursuit of dangerous clumps 2In the pursuit of dangerous clumps 3
    (Date:6/18/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market announces that its Wocket® smart wallet will be ... Mark", scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive ... NXT-ID, Inc.,s CEO Gino Pereira will be discussing ...
    (Date:6/17/2015)... GERMANTOWN, Maryland , and HILDEN, Germany ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) today launched ... DNA evidence in forensic laboratories in the United ... integrated solution to simultaneously analyze multiple key genomic markers (short ... Investigator ® Quality Sensor to evaluate the quality of ...
    (Date:6/17/2015)... Fla. , June 17, 2015  Crossmatch™, ... today announced that its U.are.U ® 4500 ... Togo,s Eateries, Inc., a ... sandwich chain, to increase security, improve accountability and ... readers enable instant, non-repudiable identity confirmation for employee ...
    Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
    ... Sildenafil and other "impotence drugs" that boost the production of ... an erection now also show promise in unmasking cancer cells ... say scientists at the Johns Hopkins Kimmel Cancer Center. , ... tumors showed that tumor size decreased two- and threefold in ...
    ... many as 18 percent of adults who have no history ... stroke, according to results of a large national study published ... one of the JAMA/Archives journals. , Using brain imaging to ... have had an undiagnosed or silent stroke, according to background ...
    ... in imaging software and machinery, also known as a 64-slice ... and accurate means of tracking blood that has been slowed ... it took them less than half the time of exercise ... warning of vessels more likely to become blocked and cause ...
    Cached Biology News:'Erectile dysfunction' drugs heighten natural anti-cancer activity 2Stroke symptoms common among general population 2Fast test for low blood flow in dogs detects early heart trouble 2Fast test for low blood flow in dogs detects early heart trouble 3Fast test for low blood flow in dogs detects early heart trouble 4
    Identify and characterize Phosphoinositide (PI(4,5)P2) binding...
    Recommended fro Western blotting application...
    ... Immunogen corresponds to amino acids 2-105 ... has been successfully used in Western blot, ... blot, this antibody detects an ~ 60 ... has also been used in immunoprecipitation and ...
    ... KLF15 is a Cys2-His2 zinc finger gene. ... liver, kidneys, heart, and skeletal muscle. ... produced in rabbits immunized with a synthetic ... KLF15 with an internal ID of P03590 ...
    Biology Products: